Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Short-term Investments (2012 - 2026)

Kamada's (KMDA) quarterly Short-term Investments came in at $40.7 million in Q2 2026, up 1.08% quarter-over-quarter from $40.2 million in Q1 2026.

Analysis

Kamada (KMDA) Short-term Investments (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Short-term Investments for 15 consecutive years, with $40.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Short-term Investments changed N/A year-over-year to $40.7 million; the trailing twelve-month figure through Jun 2026 stood at $40.7 million (changed N/A YoY), and the FY2025 full-year result was $75.5 million, down 3.78% from the prior year.
  • Short-term Investments climbed to $40.7 million in Q2 2026 per KMDA's latest filing, from $40.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $78.4 million in Q4 2024 and bottomed at $2.8 million in Q4 2022.
  • Historically, Short-term Investments has averaged $48.9 million across 5 years, with a median of $48.2 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Short-term Investments plunged 97.75% in 2022, then surged 1854.37% in 2023.
  • Over 5 years, Short-term Investments stood at $2.8 million in 2022, then soared by 1854.37% to $55.6 million in 2023, then soared by 40.97% to $78.4 million in 2024, then declined by 3.78% to $75.5 million in 2025, then tumbled by 46.12% to $40.7 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods registered $40.7 million, $40.2 million, and $75.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.66 Mn
Mar 31, 2026 40.23 Mn
Dec 31, 2025 75.47 Mn
Dec 31, 2024 78.44 Mn
Dec 31, 2023 55.64 Mn
Dec 31, 2022 2.85 Mn
Dec 31, 2021 126.71 Mn
Jun 30, 2021 36.14 Mn
Mar 31, 2021 48.04 Mn
Dec 31, 2020 39.07 Mn
Sep 30, 2020 47.23 Mn
Jun 30, 2020 47.27 Mn
Mar 31, 2020 47.12 Mn
Dec 31, 2019 31.25 Mn
Sep 30, 2019 39.38 Mn
Jun 30, 2019 38.12 Mn
Mar 31, 2019 33.80 Mn
Dec 31, 2018 32.50 Mn
Sep 30, 2018 32.05 Mn
Jun 30, 2018 32.23 Mn